Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor

James A Martin1, Erin Forest, Joel A Block

  • 1Department of Orthopaedic Surgery, The University of Iowa, Iowa City, Iowa 52242, USA. james-martin@uiowa.edu

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|October 2, 2002
PubMed

Insights

Telomerase activation in chondrosarcoma cells drives aggressive tumor behavior and potential for metastasis. This finding offers new insights into cartilage cancer progression and treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Human chondrosarcomas exhibit resistance to chemotherapy and radiation.
  • Tumor size and histology are unreliable predictors of chondrosarcoma recurrence and metastasis.
  • Understanding chondrosarcoma proliferation and invasion mechanisms is crucial for clinical management.

Purpose of the Study:

  • To investigate the role of telomerase expression in the malignant behavior of chondrosarcomas.
  • To determine if telomerase activation contributes to tumor cell proliferation and invasiveness.

Main Methods:

  • Detection of telomerase expression in human chondrosarcoma samples.
  • Culturing chondrosarcoma cells to observe changes in telomerase activity and tumor suppressor function.
  • Assessing cell proliferation, morphological changes, and invasive activity in cultured cells.

Main Results:

  • Telomerase expression was detected in 7 out of 16 chondrosarcomas.
  • Telomerase-negative chondrosarcoma cells acquired significant telomerase activity in culture.
  • Acquired telomerase activity correlated with loss of tumor suppressor function, increased proliferation, and enhanced invasive behavior.

Conclusions:

  • Telomerase activation is a key mechanism contributing to the aggressive phenotype of chondrosarcoma cells.
  • The interplay between telomerase activation and loss of cell cycle control promotes the emergence of highly invasive cancer cells.
  • These findings may improve understanding of malignant transformation and metastasis in cartilage neoplasms.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...